1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Medrol Veriderm: new trials by email Literature Review of Medrol Veriderm trials Research Report on Medrol Veriderm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors Methylprednisolone, Prednisone, Quality-of-Life Assessment - Cranial Nerve Disorder, Head and Neck Carcinoma | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 35 | 2019-10-16 | 2026-06-26 |
| Gene Therapy for Fanconi Anemia Bone Marrow Aspiration, Filgrastim, Genetically Engineered Hematopoietic Stem Progenitor Cells - Fanconi Anemia | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 3 | 2012-02-22 | 2024-05-17 |
Cranial Nerve Diseases (1) · Fanconi Anemia (1) · Oropharyngeal Neoplasms (1)
Fred Hutchinson Cancer Center (1) · M.D. Anderson Cancer Center (1)
United States (2)